Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Medtronic Gets FDA Nod for Blood Sugar Monitoring Device
Link ID 2816
Title Medtronic Gets FDA Nod for Blood Sugar Monitoring Device
Url http://www.medscape.com/viewarticle/569425?src=rss
Description Medtronic Inc said U.S. health regulators approved its blood sugar monitoring device, the CGMS iPro Recorder. Reuters Health Information
Category Articles > Business of Medicine
Keywords
Date Jan 31, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. WHO Reports Tamiflu-Resistant Flu in U.S., Canada
  The main flu virus circulating in the United States and Canada has shown "elevated resistance" to Tamiflu (oseltamivir), in line with findings in parts of Europe, the World Health Organisation (WHO) said on Friday. Reuters Health Information
Category:   Articles > Business of Medicine


2. Enoxaparin Now Affected by Heparin Contaminant
  Some countries have recalled affected batches, although no increase in adverse reactions has been seen. Medscape Medical News
Category:   Articles > Business of Medicine


3. Case Volume and Hospital Compliance With Evidence-based Processes of Care
  Hospitals with higher complex medical and surgical case volumes are assumed to be more likely to implement evidence-based processes of care. But is this really the case?
International Journal for Quality in Health Care
Category:   Articles > Business of Medicine


4. Schering, Merck Shares Fall on Congressional Probe
  Shares of Schering-Plough Corp and Merck & Co were down on Wednesday after U.S. lawmakers said they would look into allegations that the drugmakers were withholding data from a study of their shared cholesterol medicine Vytorin. Reuters Health Information
Category:   Articles > Business of Medicine


5. Heart-Imaging Agent Gets FDA Approval
  Drug makers CV Therapeutics and Astellas Pharma Inc said on Friday the U.S. Food and Drug Administration (FDA) had approved their heart-imaging agent regadenoson, also called Lexiscan. Reuters Health Information
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS